Yanli Qu

1.0k total citations
27 papers, 301 citations indexed

About

Yanli Qu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanli Qu has authored 27 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanli Qu's work include Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Yanli Qu is often cited by papers focused on Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Yanli Qu collaborates with scholars based in China, United States and Hong Kong. Yanli Qu's co-authors include Baogui Xin, Kun Liu, Xianbo Yu, Yong Tang, Haifeng Wang, Zhenqiang Sun, Yong Tang, Hong Yu, Ning Zhou and Chunlei Xu and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Annals of Oncology and International Journal of Environmental Research and Public Health.

In The Last Decade

Yanli Qu

24 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Qu China 9 116 89 78 41 40 27 301
Xianhua Tan China 6 175 1.5× 127 1.4× 58 0.7× 34 0.8× 27 0.7× 7 290
Séverine Sarp Switzerland 9 119 1.0× 196 2.2× 109 1.4× 76 1.9× 21 0.5× 18 398
Larry G. Maxwell United States 8 111 1.0× 199 2.2× 49 0.6× 76 1.9× 17 0.4× 12 528
Hala El‐Said Egypt 11 188 1.6× 57 0.6× 111 1.4× 36 0.9× 11 0.3× 36 403
A Stone United Kingdom 8 35 0.3× 134 1.5× 54 0.7× 126 3.1× 39 1.0× 22 325
Danielle Crawley United Kingdom 12 142 1.2× 112 1.3× 117 1.5× 146 3.6× 33 0.8× 33 381
Naoko I. Simonds United States 9 92 0.8× 83 0.9× 122 1.6× 60 1.5× 20 0.5× 12 315
Nuno Sousa Portugal 8 76 0.7× 79 0.9× 41 0.5× 45 1.1× 17 0.4× 25 209
Magdalena Benetkiewicz France 14 139 1.2× 159 1.8× 110 1.4× 104 2.5× 15 0.4× 18 413
Geòrgia Anguera Spain 11 76 0.7× 136 1.5× 48 0.6× 116 2.8× 15 0.4× 43 281

Countries citing papers authored by Yanli Qu

Since Specialization
Citations

This map shows the geographic impact of Yanli Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Qu more than expected).

Fields of papers citing papers by Yanli Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Qu. The network helps show where Yanli Qu may publish in the future.

Co-authorship network of co-authors of Yanli Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Qu. A scholar is included among the top collaborators of Yanli Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Qu. Yanli Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wang, Wei, Zubing Mei, Y. Chen, et al.. (2024). Immune checkpoint inhibitors for patients with mismatch repair deficient or microsatellite instability-high advanced cancers: a meta-analysis of phase I–III clinical trials. International Journal of Surgery. 111(1). 1357–1372. 1 indexed citations
5.
Qu, Yanli, Ning Zhou, Wei Wang, et al.. (2024). Camrelizumab combined with apatinib for unresectable, metastatic esophageal squamous cell carcinoma: a single-center, single-arm, prospective study. Journal of Gastrointestinal Oncology. 15(1). 1–11.
6.
Dong, Rui, Yanli Qu, Yuan Liu, et al.. (2024). Isomalto-Oligosaccharide Potentiates Alleviating Effects of Intermittent Fasting on Obesity-Related Cognitive Impairment during Weight Loss and the Rebound Weight Gain. Journal of Agricultural and Food Chemistry. 72(43). 23875–23892. 6 indexed citations
7.
Chen, Yue, et al.. (2023). Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer. World Journal of Surgical Oncology. 21(1). 174–174. 3 indexed citations
8.
Huang, Lan, et al.. (2022). DenSec: Secreted Protein Prediction in Cerebrospinal Fluid Based on DenseNet and Transformer. Mathematics. 10(14). 2490–2490. 2 indexed citations
9.
Li, Hanming, et al.. (2021). Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer. Frontiers in Oncology. 11. 726613–726613. 3 indexed citations
10.
Qu, Yanli, Zheng Wang, Lijun Wang, et al.. (2021). Pneumonitis, appendicitis, and biliary obstruction during toripalimab treatment in a patient with extensive-stage small-cell lung cancer: a case report. Annals of Palliative Medicine. 10(8). 9267–9275. 6 indexed citations
11.
Qu, Yanli, et al.. (2020). 150P Real-world assessment of the treatment patterns associated with unresectable advanced and metastatic gastric cancer in China. Annals of Oncology. 31. S1298–S1299. 1 indexed citations
13.
Zhang, Qing, et al.. (2019). Initial Platelet-To-Lymphocyte Count As Prognostic Factor in Limited-Stage Small Cell Lung Cancer. Biomarkers in Medicine. 13(4). 249–258. 9 indexed citations
14.
Xin, Baogui & Yanli Qu. (2019). Effects of Smart City Policies on Green Total Factor Productivity: Evidence from a Quasi-Natural Experiment in China. International Journal of Environmental Research and Public Health. 16(13). 2396–2396. 59 indexed citations
16.
Han, Mei, et al.. (2017). Decreased expression of the ATM gene linked to poor prognosis for gastric cancer of different nationalities in Xinjiang. Pathology - Research and Practice. 213(8). 908–914. 7 indexed citations
17.
Xu, Chunlei, et al.. (2016). UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 78(1). 119–130. 34 indexed citations
19.
Yang, Xiaoyu, Jinsong Li, Zhihong Lu, et al.. (2015). Adiponectin Gene Polymorphisms are Associated with Increased Risk of Colorectal Cancer. Medical Science Monitor. 21. 2595–2606. 14 indexed citations
20.
Gao, Ya, Yuxia Zhao, Hong Yu, et al.. (2014). PARP-1 rs3219073 Polymorphism May Contribute to Susceptibility to Lung Cancer. Genetic Testing and Molecular Biomarkers. 18(11). 736–740. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026